Interventional procedures guidance Published: 16 January 2019
The programme provides a comprehensive review of the diagnosis, investigation and management of patients with liver disease across outpatient, acute take and intensive care settings.
Alcohol-Related Disease: Meeting the challenge of improved quality of care and better use of resources
Recently, much attention has focused on social policy and measures to reduce drinking.
A recently formed health consortium has been awarded £7 million by Innovate UK to ensure more patients benefit from a new generation of breakthrough therapies.
Alcohol screening together with referral or intervention is becoming part of routine practice in England.
Esmya is indicated for the pre-operative and intermittent treatment of moderate to severe symptoms of uterine fibroids in women of reproductive age. However, following reports of serious liver injury, the European Medicines Agency (EMA), and the Medicines and Healthcare products Regulatory Agency (MHRA) have issued the following advice.
Hirschfield GM, et al. Gut 2018;0:1–27. doi:10.1136/gutjnl-2017-315259
A study has revealed that a new scanning technology could almost halve the number of liver biopsies carried out on people with fatty liver disease.